BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 14991540)

  • 21. Improved immunohistochemical evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma with 'MCW melanoma cocktail'--a mixture of monoclonal antibodies to MART-1, Melan-A, and tyrosinase.
    Shidham VB; Qi D; Rao RN; Acker SM; Chang CC; Kampalath B; Dawson G; Machhi JK; Komorowski RA
    BMC Cancer; 2003 May; 3():15. PubMed ID: 12735792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical studies of conjunctival nevi and melanomas.
    Jakobiec FA; Bhat P; Colby KA
    Arch Ophthalmol; 2010 Feb; 128(2):174-83. PubMed ID: 20142539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma.
    Granter SR; Weilbaecher KN; Quigley C; Fletcher CD; Fisher DE
    Am J Dermatopathol; 2001 Jun; 23(3):185-9. PubMed ID: 11391097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Application of sentinel lymph node biopsy in patients with melanoma].
    Ren M; Kong YY; Cai X; Shen XX; Lyu JJ
    Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):360-365. PubMed ID: 29783803
    [No Abstract]   [Full Text] [Related]  

  • 25. S100, HMB-45, and Melan-A negative primary melanoma.
    Shinohara MM; Deubner H; Argenyi ZB
    Dermatol Online J; 2009 Sep; 15(9):7. PubMed ID: 19930994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Stealth" melanoma cells in histology-negative sentinel lymph nodes.
    Itakura E; Huang RR; Wen DR; Cochran AJ
    Am J Surg Pathol; 2011 Nov; 35(11):1657-65. PubMed ID: 21997686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reticulin and NM23 staining in the interpretation of lymph nodal nevus rests.
    Kanner WA; Barry CI; Smart CN; Frishberg DP; Binder SW; Wick MR
    Am J Dermatopathol; 2013 Jun; 35(4):452-7. PubMed ID: 23694823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of melanocyte differentiation antigens and ki-67 in nodal nevi and comparison of ki-67 expression with metastatic melanoma.
    Lohmann CM; Iversen K; Jungbluth AA; Berwick M; Busam KJ
    Am J Surg Pathol; 2002 Oct; 26(10):1351-7. PubMed ID: 12360050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microphthalmia transcription factor: a sensitive and specific marker for malignant melanoma in cytologic specimens.
    Dorvault CC; Weilbaecher KN; Yee H; Fisher DE; Chiriboga LA; Xu Y; Chhieng DC
    Cancer; 2001 Oct; 93(5):337-43. PubMed ID: 11668469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A).
    Clarkson KS; Sturdgess IC; Molyneux AJ
    J Clin Pathol; 2001 Mar; 54(3):196-200. PubMed ID: 11253130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The immunohistochemical identification of human oral mucosal melanocytes.
    Barrett AW; Raja AM
    Arch Oral Biol; 1997 Jan; 42(1):77-81. PubMed ID: 9134118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minimally invasive staging of patients with melanoma: sentinel lymphadenectomy and detection of the melanoma-specific proteins MART-1 and tyrosinase by reverse transcriptase polymerase chain reaction.
    Goydos JS; Ravikumar TS; Germino FJ; Yudd A; Bancila E
    J Am Coll Surg; 1998 Aug; 187(2):182-8; discussion 188-90. PubMed ID: 9704966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The new AJCC guidelines in practice: utility of the MITF immunohistochemical stain in the evaluation of single-cell metastasis in melanoma sentinel lymph nodes.
    Hutchens KA; Heyna R; Mudaliar K; Wojcik E
    Am J Surg Pathol; 2013 Jun; 37(6):933-7. PubMed ID: 23629445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KBA.62: a useful marker for primary and metastatic melanomas.
    Pagès C; Rochaix P; al Saati T; Valmary-Degano S; Boulinguez S; Launay F; Carle P; Lauwers F; Payoux P; Le Guellec S; Brousset P; Lamant L
    Hum Pathol; 2008 Aug; 39(8):1136-42. PubMed ID: 18495211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is MAGE-1 expression in metastatic malignant melanomas really helpful?
    Gajjar NA; Cochran AJ; Binder SW
    Am J Surg Pathol; 2004 Jul; 28(7):883-8. PubMed ID: 15223957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant melanoma involving the ovary: a clinicopathologic and immunohistochemical study of 23 cases.
    Gupta D; Deavers MT; Silva EG; Malpica A
    Am J Surg Pathol; 2004 Jun; 28(6):771-80. PubMed ID: 15166669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of MART-1, tyrosinase, and SM5-1 in primary and metastatic melanoma.
    Reinke S; Königer P; Herberth G; Audring H; Wang H; Ma J; Guo Y; Sterry W; Trefzer U
    Am J Dermatopathol; 2005 Oct; 27(5):401-6. PubMed ID: 16148409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Staining of melanocytic neoplasms by melanoma antigen recognized by T cells.
    Mehregan DR; Hamzavi I
    Am J Dermatopathol; 2000 Jun; 22(3):247-50. PubMed ID: 10871068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneity of Metastatic Melanoma:  Correlation of MITF With Its Transcriptional Targets MLSN1, PEDF, HMB-45, and MART-1.
    Zand S; Buzney E; Duncan LM; Dadras SS
    Am J Clin Pathol; 2016 Sep; 146(3):353-60. PubMed ID: 27515936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of tyrosinase, MIA and MART-1 in sentinel lymph nodes of patients with malignant melanoma.
    Hochberg M; Lotem M; Gimon Z; Shiloni E; Enk CD
    Br J Dermatol; 2002 Feb; 146(2):244-9. PubMed ID: 11903234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.